US FDA panel backs Medtronic drug-coated stent

WASHINGTON Wed Oct 10, 2007 5:26pm EDT

Related Topics

WASHINGTON Oct 10 (Reuters) - Medtronic Inc's (MDT.N) drug-coated Endeavor heart stent should be approved, a U.S. advisory panel unanimously said on Wednesday.

The Food and Drug Administration usually follows panel recommendations. Medtronic expects a final FDA ruling by year-end. (Reporting by Lisa Richwine)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.